| 1. |
全國錐體外系疾病研討會. 帕金森病及帕金森綜合征的診斷標準和鑒別診斷[J]. 臨床薈萃, 1986, 18(5):21.
|
| 2. |
Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009)[J]. Neurology, 2009, 72(21):S1-S136.
|
| 3. |
馮濤. 解讀中國帕金森病治療指南[J]. 中國實用內科雜志, 2010(11):986-988.
|
| 4. |
Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China:prevalence in Beijing, Xian, and Shanghai[J]. Lancet, 2005, 365(9459):595-597.
|
| 5. |
Gui YX, Wan Y, Xiao Q, et al. Verification of expressions of Kir2 as potential peripheral biomarkers in lymphocytes from patients with Parkinson's disease[J]. Neurosci Lett, 2011, 505(2):104-108.
|
| 6. |
Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J]. Neurology, 2007, 68(5):384-386.
|
| 7. |
周東. 神經病學[M]. 北京:高等教育出版社, 2011:253.
|
| 8. |
范清秋, 趙華, 封秀琴. 老年住院患者照護者對預防跌倒的認知調查[J]. 中華老年醫學雜志, 2008, 27(11):875-876.
|
| 9. |
Persch LN, Ugrinowitsch C, Pereira G, et al. Strength training improves fall-related gait kinematics in the elderly:a randomized controlled trial[J]. Clin Biomech (Bristol, Avon), 2009, 24(10):819-825.
|
| 10. |
Lloyd BD, Williamson DA, Singh NA, et al. Recurrent and injurious falls in the year following hip frature:a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study[J]. J Gerontol A Biol Sci Med Sci, 2009, 64(5):599-609.
|